Literature DB >> 34049897

Suspend intellectual property rights for covid-19 vaccines.

Priti Krishtel1, Rohit Malpani.   

Abstract

Entities:  

Year:  2021        PMID： 34049897     DOI： 10.1136/bmj.n1344

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Public support in the United States for global equity in vaccine pricing.

Authors:  Yee Chan; Gaurav Datt; Asadul Islam; Birendra Rai; Liang C Wang
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

2.  University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.

Authors:  Matthew Herder; E Richard Gold; Srinivas Murthy
Journal:  Healthc Policy       Date:  2022-05

Review 3.  Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

Authors:  Gaurav Joshi; Pobitra Borah; Shweta Thakur; Praveen Sharma; Ramarao Poduri
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

4.  Rethinking the International Response System to Global Health Threats: Strengthening International Collaboration to Ensure Vaccine Equity and Combat Vaccination Hesitancy.

Authors:  Ramin Walter Parsa-Parsi
Journal:  South Med J       Date:  2022-03       Impact factor: 0.954

Review 5.  Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Authors:  Mohammad Reza Zinatizadeh; Peyman Kheirandish Zarandi; Maryam Zinatizadeh; Mohammad Hadi Yousefi; Jaffar Amani; Nima Rezaei
Journal:  Biomed Pharmacother       Date:  2021-12-10       Impact factor: 7.419

Review 6.  Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.

Authors:  Elaine M Louden
Journal:  Yale J Biol Med       Date:  2022-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.